Free Trial

Biomea Fusion (BMEA) Insider Trading & Ownership

Biomea Fusion logo
$4.03 -0.20 (-4.73%)
(As of 10:51 AM ET)

Biomea Fusion (NASDAQ:BMEA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
27.57%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$100,600.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get BMEA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Biomea Fusion stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BMEA Insider Buying and Selling by Quarter

Biomea Fusion Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/30/2024Michael J.M. HitchcockDirectorBuy10,000$10.06$100,600.00  
(Data available from 1/1/2013 forward)

BMEA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Biomea Fusion includes A2a Pharmaceuticals, Inc., Bihua Chen, Franco Valle, and Michael J.M. Hitchcock. Learn more on insiders at BMEA.

27.57% of Biomea Fusion stock is owned by insiders. Learn more on BMEA's insider holdings.

The following insiders have purchased BMEA shares in the last 24 months: Bihua Chen ($12,000,000.00), and Michael J.M. Hitchcock ($100,600.00).

Insiders have purchased a total of 410,000 BMEA shares in the last 24 months for a total of $12,100,600.00 bought.

The following insider sold BMEA shares in the last 24 months: A2a Pharmaceuticals, Inc. ($12,604,750.00).

Insiders have sold a total of 400,000 Biomea Fusion shares in the last 24 months for a total of $12,604,750.00 sold.

Biomea Fusion Key Executives



This page (NASDAQ:BMEA) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners